GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising
GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Glenmark Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Glenmark Pharmaceuticals GLENMARK at this time. Stock is rising and might rise more.
It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.
Stock of Glenmark Pharmaceuticals (GLENMARK) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Glenmark Pharmaceuticals is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 1715.9, for a target of 1691.4 or 1671.02
GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons
Technical Breakout Stocks: How to trade FDC, Glenmark Pharma and Honasa Consumer on Wednesday? On Tuesday, Indian markets rose for the second consecutive day, with the S&P BSE Sensex up over 360 points and Nifty50 above 25,000. Gains were noted in capital goods, healthcare, IT, power, and telecom, while energy and oil & gas stocks saw declin - NEWS as on 2024-09-10 indiatimes.com
Technical Breakout Stocks: How to trade Glenmark Pharma, Piramal Pharma and Suven Life on Monday The Indian market closed in the red for the fourth consecutive day, with the Sensex falling over 1,000 points and Nifty50 below 24,900. Despite this, Glenmark Pharma, Piramal Pharma, and Suven Pharma showed positive trends. Analysts suggest a bullish outlo - NEWS as on 2024-09-08 indiatimes.com
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2024-09-05
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. - NEWS as on 2024-09-05
Glenmark to pay million as part of settlement with US authorities Glenmark Pharmaceuticals has agreed to pay USD 25 million as part of a settlement with the US Department of Justice regarding a case related to the pricing of a generic drug. Glenmark Pharmaceuticals Inc, USA, a wholly-owned subsidiary of the Mumbai-based - NEWS as on 2024-09-05 business-standard.com
Company Announcement - NEWS as on 2024-09-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 27, 2024 - NEWS as on 2024-09-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of the date of 46th Annual General Meeting and Book Closure pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. - NEWS as on 2024-08-27
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2024-08-20
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2024, titled "Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)". - NEWS as on 2024-08-19
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation - NEWS as on 2024-08-16
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2024-08-01
More announcements and NEWS
GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals
Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 11 Wed Sep 2024 | 1725.65 | 1715.15 to 1744.00 | -0.13% | 0.71 times |
| 10 Tue Sep 2024 | 1727.85 | 1713.00 to 1746.85 | 1.39% | 0.95 times |
| 09 Mon Sep 2024 | 1704.20 | 1688.30 to 1724.00 | 0.09% | 0.92 times |
| 06 Fri Sep 2024 | 1702.70 | 1695.00 to 1725.00 | -0.39% | 0.9 times |
| 05 Thu Sep 2024 | 1709.45 | 1680.00 to 1715.80 | 1.36% | 0.9 times |
| 04 Wed Sep 2024 | 1686.55 | 1666.50 to 1704.45 | -0.06% | 1.25 times |
| 03 Tue Sep 2024 | 1687.50 | 1681.50 to 1716.70 | -0.02% | 0.89 times |
| 02 Mon Sep 2024 | 1687.90 | 1683.40 to 1750.50 | -2.53% | 0.53 times |
| 30 Fri Aug 2024 | 1731.75 | 1683.15 to 1750.00 | 2.39% | 1.24 times |
| 29 Thu Aug 2024 | 1691.30 | 1676.15 to 1713.90 | 0% | 1.21 times |
| 29 Thu Aug 2024 | 1691.30 | 1676.15 to 1713.90 | 0% | 1.21 times |
| 29 Thu Aug 2024 | 1691.30 | 1676.15 to 1713.90 | -0.95% | 1.21 times |
Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance